• Mon, November 11, 2019
  • Tue, November 12, 2019

Gary Nachman Maintained (AMRX) at Hold with Decreased Target to $4 on, Nov 11th, 2019

Gary Nachman of BMO Capital, Maintained "Amneal Pharmaceuticals, Inc." (AMRX) at Hold with Decreased Target from $5 to $4 on, Nov 11th, 2019.

Gary has made no other calls on AMRX in the last 4 months.



There is 1 other peer that has a rating on AMRX. Out of the 1 peers that are also analyzing AMRX, all agrees with Gary's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Randall Stanicky of "RBC Capital" Downgraded from Buy to Hold and Decreased Target to $6 on, Thursday, July 11th, 2019

Like: 👍